Pulling SEC filings + quote and writing the call…
Pulling SEC filings + quote and writing the call…
NEOGENOMICS INC
Last earnings +4.8% on 2026-04-28
Revenue grew 10.1% YoY; but unprofitable (net margin -14.9%).
Rules-based read computed from SEC figures — no Anthropic key set. Add ANTHROPIC_API_KEY to .env.local for a full Claude analysis.
NEOGENOMICS INC shows $727M in FY2025 revenue (+10.1% YoY), a -14.9% net margin, and -12.9% ROE.
The risks, catalysts, 12-month price target and the cited SEC figures behind this rating — with Pro.
Unlock with Pro€15/mo · cancel anytime
Sources: SEC EDGAR (CIK 0001077183, latest 10-Q filed 2026-04-28) · EODHD · rules-based read · as of 6/18/2026, 1:58:23 PM.
Research and education only — not financial advice. Calls are generated from SEC filings and a delayed/third-party price feed, may be wrong or out of date, and are not a recommendation to buy or sell any security. Do your own research.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $484M | $510M | $592M | $661M | $727M |
| Gross profit | $187M | $188M | $245M | $290M | $314M |
| Operating income | -$119M | -$158M | -$108M | -$92.1M | -$116M |
| Net income | -$8.35M | -$144M | -$88.0M | -$78.7M | -$108M |
| Diluted EPS | — | — | — | — | — |
| Net margin | -1.7% | -28.3% | -14.9% | -11.9% | -14.9% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
501 tracked peers · median
Source: EODHD. Yield = trailing-12-month dividends ÷ price.
Last 90 days: 0 open-market buys · 2 sales
| 2026-06-15 | TETRAULT LYNN A. Director | Sell | 5.31K @ $11.10 | $58.9K |
| 2026-06-09 | TETRAULT LYNN A. Director | Sell | 5.31K @ $11.29 | $59.9K |
| 2026-06-01 | Kenny John P. Director | Exercise | 5.89K | |
| 2026-06-01 | Williams Felicia Director | Exercise | 23.1K | |
| 2026-06-01 | TETRAULT LYNN A. Director | Exercise | 23.1K | |
| 2026-06-01 | Perez David Brian Director | Exercise | 23.1K | |
| 2026-06-01 | Kelly Michael Aaron Director | Exercise | 23.1K | |
| 2026-06-01 | KANOVSKY STEPHEN M Director | Exercise | 23.1K |